Authors:
Flynn, AA
Pedley, RB
Green, AJ
Boxer, GM
Boden, R
Dearling, J
Bhatia, J
Begent, RHJ
Citation: Aa. Flynn et al., Effectiveness of radiolabelled antibodies for radio-immunotherapy in a colorectal xenograft model: a comparative study using the linear-quadratic formulation, INT J RAD B, 77(4), 2001, pp. 507-517
Authors:
Flynn, AA
Boxer, GM
Begent, RHJ
Pedley, RB
Citation: Aa. Flynn et al., Relationship between tumour morphology, antigen and antibody distribution measured by fusion of digital phosphor and photographic images, CANCER IMMU, 50(2), 2001, pp. 77-81
Authors:
Flynn, AA
Green, AJ
Pedley, RB
Boxer, GM
Boden, R
Begent, RHJ
Citation: Aa. Flynn et al., A mouse model for calculating the absorbed beta-particle dose from I-131- and Y-90-labeled immunoconjugates, including a method for dealing with heterogeneity in kidney and tumor, RADIAT RES, 156(1), 2001, pp. 28-35
Authors:
Green, AJ
Johnson, CJ
Adamson, KL
Begent, RHJ
Citation: Aj. Green et al., Mathematical model of antibody targeting: important parameters defined using clinical data, PHYS MED BI, 46(6), 2001, pp. 1679-1693
Authors:
Cooke, SP
Boxer, GM
Lawrence, L
Pedley, RB
Spencer, DIR
Begent, RHJ
Chester, KA
Citation: Sp. Cooke et al., A strategy for antitumor vascular therapy by targeting the vascular endothelial growth factor : receptor complex, CANCER RES, 61(9), 2001, pp. 3653-3659
Authors:
Pedley, RB
Hill, SA
Boxer, GM
Flynn, AA
Boden, R
Watson, R
Dearling, J
Chaplin, DJ
Begent, RHJ
Citation: Rb. Pedley et al., Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin A-4 3-O-phosphate, CANCER RES, 61(12), 2001, pp. 4716-4722
Authors:
Webley, SD
Francis, RJ
Pedley, RB
Sharma, SK
Begent, RHJ
Hartley, JA
Hochhauser, D
Citation: Sd. Webley et al., Measurement of the critical DNA lesions produced by antibody-directed enzyme prodrug therapy (ADEPT) in vitro, in vivo and in clinical material, BR J CANC, 84(12), 2001, pp. 1671-1676
Authors:
Mayer, A
Tsiompanou, E
O'Malley, D
Boxer, GM
Bhatia, J
Flynn, AA
Chester, KA
Davidson, BR
Lewis, AAM
Winslet, MC
Dhillon, AP
Hilson, AJW
Begent, RHJ
Citation: A. Mayer et al., Radioimmunoguided surgery in colorectal cancer using a genetically engineered anti-CEA single-chain Fv antibody, CLIN CANC R, 6(5), 2000, pp. 1711-1719
Authors:
Boehm, MK
Corper, AL
Wan, T
Sohi, MK
Sutton, BJ
Thornton, JD
Keep, PA
Chester, KA
Begent, RHJ
Perkins, SJ
Citation: Mk. Boehm et al., Crystal structure of the anti-(carcinoembryonic antigen) single-chain Fv antibody MFE-23 and a model for antigen binding based on intermolecular contacts, BIOCHEM J, 346, 2000, pp. 519-528
Citation: Mj. Verhaar-langereis et al., Anaphylactic reaction to radioimmunotherapy despite plasmapheresis to remove anti-mouse antibodies, J ROY S MED, 93(2), 2000, pp. 75-76
Authors:
Bhatia, J
Sharma, SK
Chester, KA
Pedley, RB
Boden, RW
Read, DA
Boxer, GM
Michael, NP
Begent, RHJ
Citation: J. Bhatia et al., Catalytic activity of an in vivo tumor targeted anti-CEA scFv :: carboxypeptidase G2 fusion protein, INT J CANC, 85(4), 2000, pp. 571-577
Authors:
Flynn, AA
Green, AJ
Boxer, GM
Casey, JL
Pedley, RB
Begent, RHJ
Citation: Aa. Flynn et al., A novel technique, using radioluminography, for the measurement of uniformity of radiolabelled antibody distribution in a colorectal cancer xenograftmodel, INT J RAD O, 43(1), 1999, pp. 183-189
Authors:
Flynn, AA
Green, AJ
Boxer, G
Pedley, RB
Begent, RHJ
Citation: Aa. Flynn et al., A comparison of image registration techniques for the correlation of radiolabelled antibody distribution with tumour morphology, PHYS MED BI, 44(7), 1999, pp. N151-N159
Authors:
Pedley, RB
Sharma, SK
Boxer, GM
Boden, R
Stribbling, SM
Davies, L
Springer, CJ
Begent, RHJ
Citation: Rb. Pedley et al., Enhancement of antibody-directed enzyme prodrug therapy in colorectal xenografts by an antivascular agent, CANCER RES, 59(16), 1999, pp. 3998-4003
Authors:
Al-Mufti, RAM
Pedley, RB
Marshall, D
Begent, RHJ
Hilson, A
Winslet, MC
Hobbs, KEF
Citation: Ram. Al-mufti et al., In vitro assessment of Lipiodol-targeted radiotherapy for liver and colorectal cancer cell lines, BR J CANC, 79(11-12), 1999, pp. 1665-1671